FI110777B - Menetelmä 7-[7-(S)-amino-5-atsaspiro[2.4]heptan-5-yyli]-8-kloori-6-fluori-1-[(1R,2S)-2-fluorisyklopropyyli]-4-okso-1,4-dihydrokinoliini-3-karboksyylihapon 3/2-hydraatin saamiseksi selektiivisesti - Google Patents

Menetelmä 7-[7-(S)-amino-5-atsaspiro[2.4]heptan-5-yyli]-8-kloori-6-fluori-1-[(1R,2S)-2-fluorisyklopropyyli]-4-okso-1,4-dihydrokinoliini-3-karboksyylihapon 3/2-hydraatin saamiseksi selektiivisesti Download PDF

Info

Publication number
FI110777B
FI110777B FI944174A FI944174A FI110777B FI 110777 B FI110777 B FI 110777B FI 944174 A FI944174 A FI 944174A FI 944174 A FI944174 A FI 944174A FI 110777 B FI110777 B FI 110777B
Authority
FI
Finland
Prior art keywords
weak
hydrate
azaspiro
oxo
fluoro
Prior art date
Application number
FI944174A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI944174A0 (fi
FI944174A (fi
Inventor
Youichi Kimura
Katsuhiro Kawakami
Norimasa Mikata
Keiji Uchiyama
Tazuo Uemura
Yusuke Yukimoto
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of FI944174A0 publication Critical patent/FI944174A0/fi
Publication of FI944174A publication Critical patent/FI944174A/fi
Application granted granted Critical
Publication of FI110777B publication Critical patent/FI110777B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Quinoline Compounds (AREA)
FI944174A 1993-09-10 1994-09-09 Menetelmä 7-[7-(S)-amino-5-atsaspiro[2.4]heptan-5-yyli]-8-kloori-6-fluori-1-[(1R,2S)-2-fluorisyklopropyyli]-4-okso-1,4-dihydrokinoliini-3-karboksyylihapon 3/2-hydraatin saamiseksi selektiivisesti FI110777B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22538093 1993-09-10
JP22538093 1993-09-10

Publications (3)

Publication Number Publication Date
FI944174A0 FI944174A0 (fi) 1994-09-09
FI944174A FI944174A (fi) 1995-03-11
FI110777B true FI110777B (fi) 2003-03-31

Family

ID=16828452

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944174A FI110777B (fi) 1993-09-10 1994-09-09 Menetelmä 7-[7-(S)-amino-5-atsaspiro[2.4]heptan-5-yyli]-8-kloori-6-fluori-1-[(1R,2S)-2-fluorisyklopropyyli]-4-okso-1,4-dihydrokinoliini-3-karboksyylihapon 3/2-hydraatin saamiseksi selektiivisesti

Country Status (32)

Country Link
US (1) US5693814A (fr)
EP (1) EP0643058B1 (fr)
JP (1) JP3793583B2 (fr)
KR (1) KR100336247B1 (fr)
CN (1) CN1057297C (fr)
AT (1) ATE181069T1 (fr)
AU (1) AU679094B2 (fr)
BG (1) BG61767B1 (fr)
CA (1) CA2131761C (fr)
CZ (3) CZ284837B6 (fr)
DE (1) DE69418953T2 (fr)
DK (1) DK0643058T3 (fr)
ES (1) ES2136142T3 (fr)
FI (1) FI110777B (fr)
GE (1) GEP19981355B (fr)
GR (1) GR3031012T3 (fr)
HR (1) HRP940506B1 (fr)
HU (1) HU224970B1 (fr)
IL (2) IL110909A (fr)
LV (1) LV11322B (fr)
MY (1) MY112574A (fr)
NO (2) NO307419B1 (fr)
NZ (1) NZ264422A (fr)
PL (1) PL180163B1 (fr)
RU (1) RU2126402C1 (fr)
SG (1) SG50492A1 (fr)
SI (1) SI9400349B (fr)
SK (3) SK283189B6 (fr)
TW (1) TW393481B (fr)
UA (1) UA41312C2 (fr)
YU (1) YU49132B (fr)
ZA (1) ZA946853B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE69802692D1 (de) 1997-06-26 2002-01-10 Dong Wha Pharm Ind Co Ltd Derivate der chinoloncarbonsäure
JP2001300293A (ja) * 2000-04-25 2001-10-30 Nipro Corp 無機無水物または有機無水物の製造法
ITMI20032259A1 (it) 2003-11-20 2005-05-21 Chemi Spa Nuovo polimorfo dell'acido 1-ciclopropil-7-(s,s-2,8-diazabciclo-4.3.0-non-8-il)-6-fluoro-1,4-diidro-8-metossi-4-oxo-chinolin carbossilico cloridrato e metodi per la sua preparazione
CN102718746B (zh) * 2012-06-18 2014-10-29 南京优科生物医药研究有限公司 西他沙星富马酸盐晶型a和其制药用途
CN103539776B (zh) * 2012-07-16 2016-06-08 深圳信立泰药业股份有限公司 一种西他沙星晶型及其制备方法
CN106749174B (zh) * 2016-12-06 2019-06-18 山东裕欣药业有限公司 一种西他沙星二水合物晶型、制备方法及其组合物片剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE203719C (fr) * 1907-11-02 1908-10-20
NO166131C (no) * 1985-06-20 1991-06-05 Daiichi Seiyaku Co Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser.
IL90062A (en) * 1988-04-27 1994-10-07 Daiichi Seiyaku Co History of pyridonecarboxylic acid, their preparation and pharmaceutical preparations containing them
CA1332605C (fr) * 1988-10-03 1994-10-18 Yasuhiro Nishitani Acides pyridonecarboxyliques
TW208013B (fr) * 1990-03-01 1993-06-21 Daiichi Co Ltd
US4994809A (en) * 1990-03-07 1991-02-19 Hughes Aircraft Company Polystatic correlating radar
MY109714A (en) * 1990-10-18 1997-04-30 Daiichi Seiyaku Co Process for preparing 8-chloroquinolone derivatives
CN1065206A (zh) * 1991-04-01 1992-10-14 战永胜 天然中草药防治早泄、淋病双效药液制法
WO1993025545A1 (fr) * 1992-06-09 1993-12-23 Korea Research Institute Of Chemical Technology Nouveaux derives de quinoleine et procedes pour leur preparation

Also Published As

Publication number Publication date
DE69418953T2 (de) 2000-01-13
KR100336247B1 (ko) 2005-08-11
HRP940506A2 (en) 1997-04-30
NZ264422A (en) 1995-07-26
EP0643058A1 (fr) 1995-03-15
PL180163B1 (pl) 2000-12-29
IL110909A0 (en) 1994-11-28
RU2126402C1 (ru) 1999-02-20
MY112574A (en) 2001-07-31
LV11322A (lv) 1996-06-20
NO992513D0 (no) 1999-05-25
US5693814A (en) 1997-12-02
YU53694A (sh) 1997-03-07
SG50492A1 (en) 1998-07-20
SK283190B6 (sk) 2003-03-04
IL110909A (en) 1998-12-06
HU9402597D0 (en) 1994-11-28
BG61767B1 (bg) 1998-05-29
PL304989A1 (en) 1995-03-20
HU224970B1 (en) 2006-04-28
JPH07126266A (ja) 1995-05-16
NO307419B1 (no) 2000-04-03
SK283189B6 (sk) 2003-03-04
CA2131761C (fr) 2002-04-30
DE69418953D1 (de) 1999-07-15
EP0643058B1 (fr) 1999-06-09
SI9400349A (en) 1995-04-30
CZ284738B6 (cs) 1999-02-17
BG99035A (bg) 1995-05-31
RU94032286A (ru) 1996-08-10
NO943313D0 (no) 1994-09-08
HRP940506B1 (en) 2000-10-31
KR950008506A (ko) 1995-04-17
CZ217694A3 (en) 1995-03-15
ES2136142T3 (es) 1999-11-16
CA2131761A1 (fr) 1995-03-11
JP3793583B2 (ja) 2006-07-05
TW393481B (en) 2000-06-11
LV11322B (en) 1996-10-20
SK283188B6 (sk) 2003-03-04
FI944174A0 (fi) 1994-09-09
CN1057297C (zh) 2000-10-11
ATE181069T1 (de) 1999-06-15
CZ284737B6 (cs) 1999-02-17
AU679094B2 (en) 1997-06-19
GR3031012T3 (en) 1999-12-31
YU49132B (sh) 2004-03-12
CZ284837B6 (cs) 1999-03-17
FI944174A (fi) 1995-03-11
CZ21598A3 (cs) 1999-02-17
NO992513L (no) 1995-03-13
CN1106006A (zh) 1995-08-02
AU7286294A (en) 1995-03-23
ZA946853B (en) 1995-04-24
DK0643058T3 (da) 1999-11-15
SK107694A3 (en) 1995-05-10
CZ21498A3 (cs) 1999-02-17
IL123910A (en) 1999-06-20
SI9400349B (sl) 2000-08-31
GEP19981355B (en) 1998-08-25
NO307753B1 (no) 2000-05-22
UA41312C2 (uk) 2001-09-17
HUT68541A (en) 1995-06-28
NO943313L (no) 1995-03-13

Similar Documents

Publication Publication Date Title
KR101667534B1 (ko) 리팍시민
CA2304702C (fr) Compositions orales de levosimendan
JP2001522780A (ja) オメプラゾールの新規な結晶形
FI110777B (fi) Menetelmä 7-[7-(S)-amino-5-atsaspiro[2.4]heptan-5-yyli]-8-kloori-6-fluori-1-[(1R,2S)-2-fluorisyklopropyyli]-4-okso-1,4-dihydrokinoliini-3-karboksyylihapon 3/2-hydraatin saamiseksi selektiivisesti
CA2530964A1 (fr) Forme cristalline du rabeprazole sodique
KR20030094358A (ko) 결정형의 오미프라졸
CZ294964B6 (cs) Způsob přípravy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)fenyl]hydrazon]propandinitrilu s optickou čistotou nad 90 %
JPH01261388A (ja) 置換キノリン誘導体
WO2000078729A1 (fr) Formes cristallines du lansoprazole
JPH03240793A (ja) アンフォテリシンｂの精製方法および組成物
ZA200302520B (en) Crystal forms of 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl] piperazine.hydrochloride.
EP0078671A2 (fr) Sels de céphalosporines et leur application dans un procédé de purification
EP1642900A1 (fr) Derive triazolobenzazepine tricyclique produit sous forme de nouvelle substance cristalline
WO2004087688A1 (fr) Nouvelles formes cristallines de gatifloxacine

Legal Events

Date Code Title Description
MA Patent expired